fda investigating risk of severe hypocalcemia in patients on dialysis receiving osteoporosis medi...
Published 3 weeks ago • 5 plays • Length 4:01
Download video MP4
Download video MP3
Similar videos
-
4:01
fda adds boxed warning for increased risk of severe hypocalcemia in patients with advanced chroni...
-
0:37
amgen’s prolia gets fda boxed warning for risk of severe hypocalcemia
-
2:07
fda approves oral daprodustat for treating anaemia in ckd patients on dialysis
-
4:33
why fda added boxed warning to denosumab for ckd?#osteoporosis #denosumabinjection #news #ckd
-
4:57
overview of parathyroid disease (causes, symptoms and treatment for hyperparathyroidism)
-
53:11
the role of dietary phosphorus in hypocalcemia
-
28:59
vascular calcification in ckd patients - prof. ziad a. massy
-
3:01
fda approval on osteoporosis
-
2:17
denosumab - xgeva - prolia in a nutshell.
-
34:34
dolores shobach, md - what's new about hypoparathyroidism
-
8:27
osteoporosis - causes, symptoms, diagnosis, treatment, pathology
-
0:45
rx may boost bone strength in kidney patients
-
2:51
understanding the long-term impact of chronic hypoparathyroidism on the kidneys
-
11:56
hypocalcemia - causes, symptoms, diagnosis, treatment, pathology
-
1:02:03
optimizing bone health in advanced kidney disease with dr kristin clemens from western university
-
11:47
hypercalcemia - causes, symptoms, diagnosis, treatment, pathology
-
30:23
1 22 23 calcium in dialysis patients
-
11:26
cascade fh disparities in familial hypercholesterolemia (fh)
-
2:34
risk factors of osteoporosis
-
1:16:53
calcified sfa disease - april 25, 2018
-
50:04
update on osteoporosis pharmacotherapy
Clip.africa.com - Privacy-policy